The European Patent Office (EPO) has published patent application EP4630453A1, titled 'GP130 Antigen-Binding Molecules', on March 18, 2026. The application was filed by VVB Bio Pte. Ltd. and includes inventors Sebastian Schaefer and Stuart Alexander Cook. The publication details specific antigen-binding molecules and their potential applications, as indicated by the IPC classifications A61K (Preparations for medical, dental or toilet purposes), A61P (Specific therapeutic activity of medicinal agents), and C07K (Peptides).

This patent publication is an informational notice of a new filing and does not introduce any new regulatory requirements or compliance obligations for regulated entities. Companies operating in the pharmaceutical and biotechnology sectors, particularly those involved in drug development or intellectual property management, may wish to note this filing for competitive intelligence or potential licensing opportunities. No immediate actions are required from a compliance perspective.